Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer

scientific article published in May 2000

Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1011275058
P356DOI10.1038/SJ.CGT.7700156
P8608Fatcat IDrelease_hrlu32birzfq5duubh4mfebyyi
P698PubMed publication ID10830716
P5875ResearchGate publication ID12486849

P2093author name stringZou Y
Perez-Soler R
Ling YH
Zong G
P433issue5
P921main subjectgene therapyQ213901
P304page(s)683-696
P577publication date2000-05-01
P1433published inCancer Gene TherapyQ15763088
P1476titleDevelopment of cationic liposome formulations for intratracheal gene therapy of early lung cancer
P478volume7

Reverse relations

cites work (P2860)
Q45863953Amphiphilic triblock copolymer poly(p-dioxanone-co-L-lactide)-block-poly(ethylene glycol), enhancement of gene expression and inhibition of lung metastasis by aerosol delivery
Q36250762Carrier-based strategies for targeting protein and peptide drugs to the lungs
Q35627914Delivery systems for pulmonary gene therapy
Q44533912Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC.
Q34403680Gene delivery with synthetic (non viral) carriers.
Q33193343Gene therapy of lung cancer
Q40775851Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes
Q33777666In vivo gene delivery by cationic tetraamino fullerene
Q36308526In vivo gene transfer of leukemia inhibitory factor (LIF) into mouse endometrium
Q35012984Intratracheally Administered 5-Azacytidine Is Effective Against Orthotopic Human Lung Cancer Xenograft Models and Devoid of Important Systemic Toxicity
Q37939968Liposomal nanomedicine for breast cancer therapy
Q40485168Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo
Q35875509Protection against TNFα-dependent liver toxicity by intraperitoneal liposome delivered DsiRNA targeting TNFα in vivo
Q31048758Stable polyplexes based on arginine-containing oligopeptides for in vivo gene delivery
Q36315150Stimuli-responsive polymers in gene delivery
Q40321762Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate
Q46926393The effect of PS content on the ability of natural membranes to fuse with positively charged liposomes and lipoplexes
Q35013566The role of new agents in the treatment of non-small cell lung cancer.
Q37978509Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery
Q34518719Vehicles for oligonucleotide delivery to tumours

Search more.